From Name:
From Email:
To Name:
To Email:

Optional Message:


Amgen says FDA approves Xgeva as a treatment for rare bone-destroying cancer complication

from The Associated Press via Fox News

Amgen's Xgeva, which is used to treat bone disorders related to cancer, received an additional U.S. marketing approval. The Food and Drug Administration approved Xgeva as a treatment for hypercalcemia of malignancy, a condition in which a patient's bones break down at an accelerated rate, the company said. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063